HOME › DRUGS › INSULIN RECOMBINANT HUMAN
ACTIVE SUBSTANCE / INN

INSULIN RECOMBINANT HUMAN

Brand name(s): HUMULIN R PEN, HUMULIN 70/30, NOVOLIN R, AFREZZA, NOVOLIN 70/30, HUMULIN R, HUMULIN 70/30 PEN
FDA LISTED
PRESCRIPTION
OVER-THE-COUNTER
BLA022472
BLA019991
ACTIVE SUBSTANCE
Insulin Recombinant Human
REGULATORS
FDA
SPONSORS / MAH
LILLY, NOVO NORDISK INC, MANNKIND
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
HUMULIN 70/30 PENBLA019717LILLYOver-the-counter
HUMULIN 70/30BLA019717LILLYOver-the-counter
NOVOLIN 70/30BLA019991NOVO NORDISK INCOver-the-counter
HUMULIN R PENBLA018780LILLYOver-the-counter
HUMULIN RBLA018780LILLYOver-the-counter
NOVOLIN RBLA019938NOVO NORDISK INCOver-the-counter
AFREZZABLA022472MANNKINDPrescription

FULL INTELLIGENCE ON INSULIN RECOMBINANT HUMAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →